• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后肠外瘘的系统管理:与结局相关的因素

Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes.

作者信息

Martinez Jose L, Luque-de-Leon Enrique, Mier Juan, Blanco-Benavides Roberto, Robledo Felipe

机构信息

General and Gastrointestinal Surgery, Centro Médico Nacional, Siglo XXI, Instituto Mexicano del Seguro Social, Cuauhtémoc #330, Col. Doctores, Deleg. Cuauhtémoc, 06725 México, D.F, México.

出版信息

World J Surg. 2008 Mar;32(3):436-43; discussion 444. doi: 10.1007/s00268-007-9304-z.

DOI:10.1007/s00268-007-9304-z
PMID:18057983
Abstract

BACKGROUND

Most enterocutaneous fistulas are postoperative in origin. Sepsis, malnutrition, and hydroelectrolytic deficit are still the most important complications to which patients with postoperative enterocutaneous fistulas (PEF) are exposed. Knowledge of prognostic factors related to specific outcomes is essential for therapeutic decision-making processes.

METHODS

We reviewed files of all consecutive patients with PEF treated in our hospital during a 10-year period. Our aim was to identify factors related to spontaneous closure, need for operative treatment, and mortality. Univariate and multivariate analyses were performed.

RESULTS

A total of 174 patients were treated. The most frequent site of origin was the small bowel (90 patients: 48 jejunal, and 42 ileal), followed in frequency by the colon (50 patients). Postoperative enterocutaneous fistula closure was achieved in 151 patients (86%), being spontaneous in 65 (37%) and surgical in 86 (49%). Factors that significantly precluded spontaneous closure were jejunal site, multiple fistulas, sepsis, high output, and hydroelectrolytic deficit at diagnosis or referral. Origin of PEF at our hospital was the only factor significantly associated with spontaneous closure. The most frequent operative indication was PEF persistence without sepsis. Factors significantly associated with the need for operative treatment were high output, jejunal site, and multiple fistulas. Closure was achieved in 84% of patients who underwent operation. A total of 23 patients died (13%). Factors associated with mortality were serum albumin <3.0 g/dl (at diagnosis or referral), high output, hydroelectrolytic deficit, multiple fistulas, jejunal site, sepsis, and a complex fistulous tract.

CONCLUSIONS

In spite of advances in management of PEF, the associated morbidity and mortality remain high. Among several variables influencing outcome, our multivariate analysis disclosed high output, jejunal site, multiple fistulas, and sepsis as independent adverse factors related to non-spontaneous closure, need for operative treatment, and/or death.

摘要

背景

大多数肠造口瘘源于术后。脓毒症、营养不良和水电解质缺乏仍是术后肠造口瘘(PEF)患者面临的最重要并发症。了解与特定结局相关的预后因素对于治疗决策过程至关重要。

方法

我们回顾了我院10年间连续治疗的所有PEF患者的病历。我们的目的是确定与自发闭合、手术治疗需求和死亡率相关的因素。进行了单因素和多因素分析。

结果

共治疗174例患者。最常见的起源部位是小肠(90例患者:48例空肠,42例回肠),其次是结肠(50例患者)。151例患者(86%)实现了术后肠造口瘘闭合,其中65例(37%)为自发闭合,86例(49%)为手术闭合。显著阻碍自发闭合的因素为空肠部位、多发瘘、脓毒症、高流量以及诊断或转诊时的水电解质缺乏。我院的PEF起源是与自发闭合显著相关的唯一因素。最常见的手术指征是无脓毒症的PEF持续存在。与手术治疗需求显著相关的因素是高流量、空肠部位和多发瘘。接受手术的患者中有84%实现了闭合。共有23例患者死亡(13%)。与死亡率相关的因素包括血清白蛋白<3.0 g/dl(诊断或转诊时)、高流量、水电解质缺乏、多发瘘、空肠部位、脓毒症和复杂的瘘管。

结论

尽管PEF的管理取得了进展,但其相关的发病率和死亡率仍然很高。在影响结局的多个变量中,我们的多因素分析显示高流量、空肠部位、多发瘘和脓毒症是与非自发闭合、手术治疗需求和/或死亡相关的独立不良因素。

相似文献

1
Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes.术后肠外瘘的系统管理:与结局相关的因素
World J Surg. 2008 Mar;32(3):436-43; discussion 444. doi: 10.1007/s00268-007-9304-z.
2
[Enterocutaneous fistulas in patients older than 70 years].70岁以上患者的肠皮肤瘘
Cir Cir. 2004 Jul-Aug;72(4):281-5.
3
What's new in postoperative enterocutaneous fistulas?术后肠皮肤瘘有哪些新进展?
World J Surg. 2008 Mar;32(3):336-8. doi: 10.1007/s00268-007-9411-x.
4
Treatment of high-output enterocutaneous fistulas with a vacuum-compaction device. A ten-year experience.使用真空压缩装置治疗高流量肠皮肤瘘:十年经验
World J Surg. 2008 Mar;32(3):430-5. doi: 10.1007/s00268-007-9235-8.
5
Factors predictive of recurrence and mortality after surgical repair of enterocutaneous fistula.肠外瘘手术后复发和死亡的预测因素。
J Gastrointest Surg. 2012 Jan;16(1):156-63; discussion 163-4. doi: 10.1007/s11605-011-1703-7. Epub 2011 Oct 15.
6
Review of a hospital experience of enterocutaneous fistula.肠外瘘的医院经验回顾
Trop Gastroenterol. 2000 Oct-Dec;21(4):197-200.
7
Outcome of 132 consecutive reconstructive operations for intestinal fistula--staged operation without primary anastomosis improved outcome in retrospective analysis.回顾性分析显示,132 例连续肠瘘重建手术的结果——分期手术而不进行一期吻合术改善了结局。
Scand J Surg. 2013;102(3):152-7. doi: 10.1177/1457496913490452.
8
[General principles of clinical and therapeutic management in postoperative external enteral fistulas].[术后肠外瘘临床及治疗管理的一般原则]
Rev Med Chir Soc Med Nat Iasi. 2008 Jul-Sep;112(3):656-61.
9
Percutaneous management of enterocutaneous fistulas.经皮处理肠皮肤瘘
AJR Am J Roentgenol. 1996 Jul;167(1):33-8. doi: 10.2214/ajr.167.1.8659416.
10
[Treatment results of enterocutaneous fistulae in patients with cancer].[癌症患者肠造口瘘的治疗结果]
Rev Gastroenterol Mex. 2005 Apr-Jun;70(2):158-63.

引用本文的文献

1
Catheter Injectable Multifunctional Biomaterial for the Treatment of Infected Enterocutaneous Fistulas.用于治疗感染性肠皮肤瘘的导管可注射多功能生物材料
Adv Sci (Weinh). 2025 May;12(20):e2414642. doi: 10.1002/advs.202414642. Epub 2025 Feb 14.
2
Analyse of patient characteristics and aetiological causes of enterocutaneous fistulas and their impacts on in-hospital mortality: a ten-year retrospective cohort study.肠皮肤瘘患者特征、病因分析及其对院内死亡率的影响:一项十年回顾性队列研究
Eur J Trauma Emerg Surg. 2025 Jan 24;51(1):58. doi: 10.1007/s00068-024-02733-2.
3
A review of chyme reinfusion: new tech solutions for age old problems.

本文引用的文献

1
Enterocutaneous fistula: are treatments improving?肠皮肤瘘:治疗方法是否在改善?
Surgery. 2006 Oct;140(4):570-6; discussion 576-8. doi: 10.1016/j.surg.2006.07.003. Epub 2006 Sep 6.
2
Current management of enterocutaneous fistula.肠皮肤瘘的当前管理
J Gastrointest Surg. 2006 Mar;10(3):455-64. doi: 10.1016/j.gassur.2005.08.001.
3
An 11-year experience of enterocutaneous fistula.肠皮肤瘘的11年经验。
食糜再输注综述:解决老问题的新技术方案
J R Soc N Z. 2022 Sep 7;54(2):161-176. doi: 10.1080/03036758.2022.2117832. eCollection 2024.
4
Composite Mesh in Incisional Hernia Repair: Unprecedented Gastric Penetration and Gastrocutaneous Fistula Formation.复合补片在切口疝修补术中:罕见的胃穿透及胃皮肤瘘形成
ACG Case Rep J. 2024 Sep 19;11(9):e01475. doi: 10.14309/crj.0000000000001475. eCollection 2024 Sep.
5
Surgical approach for a refractory enterocutaneous fistula by combining laparoscopic surgery and a planned open conversion: a case report.腹腔镜手术联合计划性开放转换治疗难治性肠造口周围瘘:1例病例报告
Surg Case Rep. 2024 Aug 14;10(1):186. doi: 10.1186/s40792-024-01987-7.
6
Entero-Cutaneous and Entero-Atmospheric Fistulas: Insights into Management Using Negative Pressure Wound Therapy.肠皮肤瘘和肠-大气瘘:负压伤口治疗管理的见解
J Clin Med. 2024 Feb 23;13(5):1279. doi: 10.3390/jcm13051279.
7
Injectable Nanoengineered Adhesive Hydrogel for Treating Enterocutaneous Fistulas.可注射的纳米工程化黏附水凝胶治疗肠外瘘。
Acta Biomater. 2024 Jan;173:231-246. doi: 10.1016/j.actbio.2023.10.026. Epub 2023 Oct 28.
8
Optimized Treatment of Nosocomial Peritonitis.医院获得性腹膜炎的优化治疗
Antibiotics (Basel). 2023 Dec 8;12(12):1711. doi: 10.3390/antibiotics12121711.
9
A review of platelet-rich plasma for enteric fistula management.富血小板血浆在肠瘘治疗中的应用综述
Front Bioeng Biotechnol. 2023 Nov 15;11:1287890. doi: 10.3389/fbioe.2023.1287890. eCollection 2023.
10
The open abdomen in trauma, acute care, and vascular and endovascular surgery: comprehensive, expert, narrative review.创伤、急症和血管及腔内血管外科中的开放性腹部:全面、专业、叙事性综述。
BJS Open. 2023 Sep 5;7(5). doi: 10.1093/bjsopen/zrad084.
Br J Surg. 2004 Dec;91(12):1646-51. doi: 10.1002/bjs.4788.
4
Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery.肠造口瘘手术后的临床结局及复发预测因素
Ann Surg. 2004 Nov;240(5):825-31. doi: 10.1097/01.sla.0000143895.17811.e3.
5
MANAGEMENT OF INTESTINAL FISTULAS.肠瘘的管理
Am J Surg. 1964 Aug;108:157-64. doi: 10.1016/0002-9610(64)90005-4.
6
External fistulas arising from the gastro-intestinal tract.源自胃肠道的外瘘。
Ann Surg. 1960 Sep;152(3):445-71. doi: 10.1097/00000658-196009000-00009.
7
A multivariate model to determine prognostic factors in gastrointestinal fistulas.一种用于确定胃肠道瘘预后因素的多变量模型。
J Am Coll Surg. 1999 May;188(5):483-90. doi: 10.1016/s1072-7515(99)00038-1.
8
Artificial nutritional support in patients with gastrointestinal fistulas.胃肠瘘患者的人工营养支持
World J Surg. 1999 Jun;23(6):570-6. doi: 10.1007/pl00012349.
9
Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?奥曲肽是肠皮肤瘘和胰腺外瘘闭合的新希望吗?
Am J Surg. 1996 Oct;172(4):386-95. doi: 10.1016/S0002-9610(96)00193-6.
10
General management of gastrointestinal fistulas. Recognition, stabilization, and correction of fluid and electrolyte imbalances.胃肠道瘘的综合管理。识别、稳定并纠正体液和电解质失衡。
Surg Clin North Am. 1996 Oct;76(5):1019-33. doi: 10.1016/s0039-6109(05)70496-5.